• Users Online: 782
  • Print this page
  • Email this page

  About Us

  About the Journal

Biomedical and Biotechnology Research Journal (BBRJ), a publication of Society of Biomedical & Biotechnology Scientists (https://www.sbbs-soc.com), is a peer-reviewed online journal with print on demand compilation of issues published. The BBRJ aims to publish current research related to biological and medical studies of biotechnology. It aims to promote communication among clinical researchers, physicians and biologist that works in areas related to Biotechnology, worldwide. The scope of "Biomedical and Biotechnology Research Journal (BBRJ) includes:

  1. Basics studies on Nano biotechnology  
  2. Basics studies on Tissue Engineering  
  3. Basics studies on Genetics  
  4. Basics studies on Tissue Modeling
  5. Basics studies on Immunology
  6. Basics studies on Infectious Diseases
  7. Nucleic Acids/Molecular Biology
  8. Physiology/Biochemistry
  9. Biochemical Engineering/Bioprocess Engineering
  10. Computational Chemistry and Molecular Drug Design
  11. Genomics and Molecular Bioinformatics
  12. Biomarkers Studies
  13. Proteomics

The journal’s full text is available online at http://www.bmbtrj.org. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository.

ISSN - Print: 2588-9834, Online: 2588-9842

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
Baidu Scholar, Biological Abstracts, BIOSIS Previews, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, Netherlands ISSN centre, ProQuest, TDNet, Wanfang Data

The journal is indexed with, or included in, the following:
DOAJ, Emerging Sources Citation Index, Scimago Journal Ranking, SCOPUS, Web of Science

Journal Ethics

Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit www.Medknow.com/EthicalGuidelines.asp

Open Access Publication and Creative Commons Licensing

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Digital Archiving

Wolters Kluwer Medknow provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.

Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.

CLOCKSS will enable any library to maintain their own archive of content from Wolters Kluwer Medknow and other publishers, with minimal technical effort and using cheaply available hardware.

Ahead of Print policy

Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.


While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:

  • "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
  • The Editorial Board has full and final approval over the content of all advertisements.
  • Advertisers will never be shown any manuscripts or other content prior to publication.

  About the Society

Established by Society of Biomedical and Biotechnology Scientists in 2006.The Society of Biomedical and Biotechnology Scientists (SBBS) is non-profit federation of international Biomedical and Biotechnology Associations, witch consist of learned Societies, universities, scientific institutes, biotech Companies and individual bio technologists whom are working to promote biomedical and biotechnology throughout the world with special references to Asian –countries. The mission of SBBS is to promote the safe, sustainable and beneficial use of the life sciences, to promote research and innovation of biomedical & biotechnology, to provide a forum for interdisciplinary and international cooperation, to improve scientific education and to facilitate an informed dialogue between scientists and the public.

The SBBS Central Office (SBBS-Co) is located in Mycobacteriology Research Center, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Membership, Journal, international congress administration, organization of executive board meetings and general assemblies, website management (www.sbbs-soc.com) are some of the main responsibilities of SBBS-Co

  Scope of the journal

The journal will cover technical and clinical studies related to health, ethical and social issues in field of Nucleic Acids/Molecular Biology, Physiology/Biochemistry, Biochemical Engineering/Bioprocess Engineering, Computational Chemistry and Molecular Drug Design, Genomics and molecular Bioinformatics, Biomarkers studies, Basics studies on tissue modeling, Proteomics. Articles with clinical interest and implications will be given preference.

    Medknow Publications   Top
Editorial board